Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond

  • Albinati, Leone
  • Bianchi, Agostina
  • Beekman, Renée
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. We acknowledge support from the Spanish Ministry of Science and Innovation to the EMBL partnership, from the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. AB is supported by an FPI fellowship from the Spanish Ministry of Science and Innovation (PRE2019-087574). LA received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement number 101034290 and CEX2020-001049-S financed by MCIN/AEI/10.13039/501100011033. RB was supported by a Junior Leader Fellowship from the la Caixa foundation and grants from the Spanish Ministry of Science and Innovation (RTI2018-096359-A-I00) and the European Hematology Association (EHA, Advanced Research Grant), and is supported by grants from the European Research Council (101039265) and the Spanish Ministry of Science and Innovation (PID2021-123635NB-I00).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

CSDE1 intracellular distribution as a biomarker of melanoma prognosis

  • Indacochea Cusirramos, Alberto
  • Guitart, Tanit
  • Boada, Aram
  • Peg, Vicente
  • Quer, Ariadna
  • Laayouni, Hafid, 1968-
  • Condal, Laura
  • Espinosa, Pablo
  • Manzano Mozo, José Luis
  • Gebauer, Fátima
RNA-binding proteins are emerging as critical modulators of oncogenic cell transformation, malignancy and therapy resistance. We have previously found that the RNA-binding protein Cold Shock Domain containing protein E1 (CSDE1) promotes invasion and metastasis of melanoma, the deadliest form of skin cancer and also a highly heterogeneous disease in need of predictive biomarkers and druggable targets. Here, we design a monoclonal antibody useful for IHC in the clinical setting and use it to evaluate the prognosis potential of CSDE1 in an exploratory cohort of 149 whole tissue sections including benign nevi and primary tumors and metastasis from melanoma patients. Contrary to expectations for an oncoprotein, we observed a global decrease in CSDE1 levels with increasing malignancy. However, the CSDE1 cytoplasmic/nuclear ratio exhibited a positive correlation with adverse clinical features of primary tumors and emerged as a robust indicator of progression free survival in cutaneous melanoma, highlighting the potential of CSDE1 as a biomarker of prognosis. Our findings provide a novel feature for prognosis assessment and highlight the intricacies of RNA-binding protein dynamics in cancer progression., A.I. and P.E. were supported by PhD4MD fellowships from the CRG and the Emerald program (Marie Skłodowska-Curie grant agreement 101034290), respectively. This work was supported by the following grants to F.G.: PGC2018-099697-B-I00 and PID2021-127948NB-I00 from the Spanish Ministry of Science and Innovation (MCIN) funded by MCIN/ AEI /10.13039/501100011033/ and by ERDF; “la Caixa” Foundation (ID 100010434) under the Grant LCF/PR/HR17/52150016; the Catalan Agency for Research and Universities (SGR-Cat-2021-01215) and intramural funds from the CRG on emergent translational research. We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

DNA methylation profiles aid to identify putative genome activation histories along lymphomagenesis

  • Albinati, Leone
  • D'Onofrio, Irene
  • Aydin, Rabia Gül
  • Toukabri, Houyem
  • Beekman, Renée
DNA methylation (DNAm) is widely used to leverage biological information in the context of cancer. Active regulatory elements marked by increased chromatin accessibility and specific transcription factor (TF) binding, such as enhancers, show tumor-specific DNAm patterns reflecting the biological forces shaping tumorigenesis. However, DNAm changes also occur at regions that are inactive at histone-mark level in fully developed tumors. Beyond hypermethylation of promoters, these changes are often overlooked, leaving their functional relevance poorly understood. By analyzing DNAm and chromatin state annotations from conventional mantle cell lymphoma (cMCL), we identified a subset of ~300 CpGs with homogeneous cMCL-specific demethylation patterns located in cMCL-inactive regions. We show that these regions contain cMCL-related TF motifs and are flanked by genes with cMCL-specific expression patterns, suggesting a potential regulatory role in lymphomagenesis. We hypothesize that these regions represent DNA demethylation imprints of genome activation prior to full-blown tumor formation, either present in its cell type of origin (COO) or during early stages of tumor formation. Altogether, we put forward a new, DNAm-centered approach to gain insights into potential early tumorigenic events, allowing us to generate novel, further explorable hypotheses to better understand the features playing a role in lymphomagenesis and beyond., This work was supported by grant RTI2018-096359-A-I00 funded by AEI/FEDER, UE and PID2021-123635NB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER. RB was supported by the ”la Caixa” Foundation (ID 100010434) via fellowship LCF/BQ/PR18/11640002. This publication is part of a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No (101034290) to L.A. The publication is part of the PRE2022-101739 fellowship funded by MICIU/AEI/10.13039/501100011033 and by FSE+ to RGA. IDO was supported by Erasmus+ exchange program. The results in this manuscript reflect only the author’s view and the funders are not responsible for any use that may be made of the information it contains.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond

  • Albinati, Leone
  • Bianchi, Agostina
  • Beekman, Renée
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. We acknowledge support from the Spanish Ministry of Science and Innovation to the EMBL partnership, from the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. AB is supported by an FPI fellowship from the Spanish Ministry of Science and Innovation (PRE2019-087574). LA received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement number 101034290 and CEX2020-001049-S financed by MCIN/AEI/10.13039/501100011033. RB was supported by a Junior Leader Fellowship from the la Caixa foundation and grants from the Spanish Ministry of Science and Innovation (RTI2018-096359-A-I00) and the European Hematology Association (EHA, Advanced Research Grant), and is supported by grants from the European Research Council (101039265) and the Spanish Ministry of Science and Innovation (PID2021-123635NB-I00).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

DNA methylation profiles aid to identify putative genome activation histories along lymphomagenesis

  • Albinati, Leone
  • D'Onofrio, Irene
  • Aydin, Rabia Gül
  • Toukabri, Houyem
  • Beekman, Renée
DNA methylation (DNAm) is widely used to leverage biological information in the context of cancer. Active regulatory elements marked by increased chromatin accessibility and specific transcription factor (TF) binding, such as enhancers, show tumor-specific DNAm patterns reflecting the biological forces shaping tumorigenesis. However, DNAm changes also occur at regions that are inactive at histone-mark level in fully developed tumors. Beyond hypermethylation of promoters, these changes are often overlooked, leaving their functional relevance poorly understood. By analyzing DNAm and chromatin state annotations from conventional mantle cell lymphoma (cMCL), we identified a subset of ~300 CpGs with homogeneous cMCL-specific demethylation patterns located in cMCL-inactive regions. We show that these regions contain cMCL-related TF motifs and are flanked by genes with cMCL-specific expression patterns, suggesting a potential regulatory role in lymphomagenesis. We hypothesize that these regions represent DNA demethylation imprints of genome activation prior to full-blown tumor formation, either present in its cell type of origin (COO) or during early stages of tumor formation. Altogether, we put forward a new, DNAm-centered approach to gain insights into potential early tumorigenic events, allowing us to generate novel, further explorable hypotheses to better understand the features playing a role in lymphomagenesis and beyond., This work was supported by grant RTI2018-096359-A-I00 funded by AEI/FEDER, UE and PID2021-123635NB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER. RB was supported by the ”la Caixa” Foundation (ID 100010434) via fellowship LCF/BQ/PR18/11640002. This publication is part of a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No (101034290) to L.A. The publication is part of the PRE2022-101739 fellowship funded by MICIU/AEI/10.13039/501100011033 and by FSE+ to RGA. IDO was supported by Erasmus+ exchange program. The results in this manuscript reflect only the author’s view and the funders are not responsible for any use that may be made of the information it contains.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

CSDE1 intracellular distribution as a biomarker of melanoma prognosis

  • Indacochea Cusirramos, Alberto
  • Guitart, Tanit
  • Boada, Aram
  • Peg, Vicente
  • Quer, Ariadna
  • Laayouni, Hafid, 1968-
  • Condal, Laura
  • Espinosa, Pablo
  • Manzano Mozo, José Luis
  • Gebauer, Fátima
RNA-binding proteins are emerging as critical modulators of oncogenic cell transformation, malignancy and therapy resistance. We have previously found that the RNA-binding protein Cold Shock Domain containing protein E1 (CSDE1) promotes invasion and metastasis of melanoma, the deadliest form of skin cancer and also a highly heterogeneous disease in need of predictive biomarkers and druggable targets. Here, we design a monoclonal antibody useful for IHC in the clinical setting and use it to evaluate the prognosis potential of CSDE1 in an exploratory cohort of 149 whole tissue sections including benign nevi and primary tumors and metastasis from melanoma patients. Contrary to expectations for an oncoprotein, we observed a global decrease in CSDE1 levels with increasing malignancy. However, the CSDE1 cytoplasmic/nuclear ratio exhibited a positive correlation with adverse clinical features of primary tumors and emerged as a robust indicator of progression free survival in cutaneous melanoma, highlighting the potential of CSDE1 as a biomarker of prognosis. Our findings provide a novel feature for prognosis assessment and highlight the intricacies of RNA-binding protein dynamics in cancer progression., A.I. and P.E. were supported by PhD4MD fellowships from the CRG and the Emerald program (Marie Skłodowska-Curie grant agreement 101034290), respectively. This work was supported by the following grants to F.G.: PGC2018-099697-B-I00 and PID2021-127948NB-I00 from the Spanish Ministry of Science and Innovation (MCIN) funded by MCIN/ AEI /10.13039/501100011033/ and by ERDF; “la Caixa” Foundation (ID 100010434) under the Grant LCF/PR/HR17/52150016; the Catalan Agency for Research and Universities (SGR-Cat-2021-01215) and intramural funds from the CRG on emergent translational research. We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme.